Khoo S - Search Results

1

Pharmacokinetic drug interactions with nevirapine.

Back D, Gibbons S, Khoo S. Back D, et al. Among authors: khoo s. J Acquir Immune Defic Syndr. 2003 Sep;34 Suppl 1:S8-14. doi: 10.1097/00126334-200309011-00003. J Acquir Immune Defic Syndr. 2003. PMID: 14562853

2

Differential expression of human immunodeficiency virus coreceptors, by CEM, CEMVBL, and CEM E1000 cells.

Owen A, Chandler B, Ford J, Khoo S, Back D. Owen A, et al. Among authors: khoo s. J Infect Dis. 2003 Mar 1;187(5):874-5; author reply 875-6. doi: 10.1086/367902. J Infect Dis. 2003. PMID: 12599066 No abstract available.

3

Intra-individual variability in lopinavir plasma trough concentrations supports therapeutic drug monitoring.

Boffito M, Back DJ, Hoggard PG, Caci A, Bonora S, Raiteri R, Sinicco A, Reynolds HE, Khoo S, Di Perri G. Boffito M, et al. Among authors: khoo s. AIDS. 2003 May 2;17(7):1107-8. doi: 10.1097/00002030-200305020-00029. AIDS. 2003. PMID: 12700470 No abstract available.

4

The effects of protease inhibitors and nonnucleoside reverse transcriptase inhibitors on p-glycoprotein expression in peripheral blood mononuclear cells in vitro.

Chandler B, Almond L, Ford J, Owen A, Hoggard P, Khoo S, Back D. Chandler B, et al. Among authors: khoo s. J Acquir Immune Defic Syndr. 2003 Aug 15;33(5):551-6. doi: 10.1097/00126334-200308150-00001. J Acquir Immune Defic Syndr. 2003. PMID: 12902797

5

Intracellular indinavir pharmacokinetics in HIV-infected patients: comparison with plasma pharmacokinetics.

Hennessy M, Clarke S, Spiers JP, Mulcahy F, Kelleher D, Meadon E, Maher B, Bergin C, Khoo S, Tjia J, Hoggard P, Back D, Barry M. Hennessy M, et al. Among authors: khoo s. Antivir Ther. 2003 Jun;8(3):191-8. Antivir Ther. 2003. PMID: 12924535 Clinical Trial.

6

Therapeutic drug monitoring.

Back D, Khoo S, Gibbons S. Back D, et al. Among authors: khoo s. J Int Assoc Physicians AIDS Care (Chic). 2002 Summer;1(3):84-5. doi: 10.1177/154510970200100301. J Int Assoc Physicians AIDS Care (Chic). 2002. PMID: 12942679 No abstract available.

7

Expression of P-glycoprotein, multidrug-resistance proteins 1 and 2 in CEM, CEM(VBL), CEM(E1000), MDCKII(MRP1) and MDCKII(MRP2) cell lines.

Owen A, Hartkoorn RC, Khoo S, Back D. Owen A, et al. Among authors: khoo s. AIDS. 2003 Oct 17;17(15):2276-8. doi: 10.1097/01.aids.0000088212.77946.65. AIDS. 2003. PMID: 14523293 No abstract available.

8

Ketoconazole and lopinavir/ritonavir coadministration: boosting beyond boosting.

Boffito M, Bonora S, Sales P, Dal Conte I, Sinicco A, Hoggard PG, Khoo S, Back DJ, Di Perri G. Boffito M, et al. Among authors: khoo s. AIDS Res Hum Retroviruses. 2003 Oct;19(10):941-2. doi: 10.1089/088922203322493148. AIDS Res Hum Retroviruses. 2003. PMID: 14585223 No abstract available.

9

Intracellular and plasma pharmacokinetics of saquinavir-ritonavir, administered at 1,600/100 milligrams once daily in human immunodeficiency virus-infected patients.

Ford J, Boffito M, Wildfire A, Hill A, Back D, Khoo S, Nelson M, Moyle G, Gazzard B, Pozniak A. Ford J, et al. Among authors: khoo s. Antimicrob Agents Chemother. 2004 Jul;48(7):2388-93. doi: 10.1128/AAC.48.7.2388-2393.2004. Antimicrob Agents Chemother. 2004. PMID: 15215085 Free PMC article. Clinical Trial.

10

Lopinavir/ritonavir combined with twice-daily 400 mg indinavir: pharmacokinetics and pharmacodynamics in blood, CSF and semen.

Isaac A, Taylor S, Cane P, Smit E, Gibbons SE, White DJ, Drake SM, Khoo S, Back DJ. Isaac A, et al. Among authors: khoo s. J Antimicrob Chemother. 2004 Aug;54(2):498-502. doi: 10.1093/jac/dkh357. Epub 2004 Jul 14. J Antimicrob Chemother. 2004. PMID: 15254024 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,191 results

Search Page

Filters